Cytosorbents Corporation
US ˙ NasdaqCM ˙ US23283X2062

Introduction

This page provides a comprehensive analysis of the known insider trading history of Bator Michael G.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Bator Michael G. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CTSO / Cytosorbents Corporation Director 151,273
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Bator Michael G.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CTSO / Cytosorbents Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTSO / Cytosorbents Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2023-12-13 CTSO BATOR MICHAEL G. 37,594 1.3300 37,594 1.3300 50,000 7 1.8400 19,173 38.35
2023-08-07 CTSO BATOR MICHAEL G. 1,000 3.2000 1,000 3.2000 3,200
2023-08-07 CTSO BATOR MICHAEL G. 1,000 3.1500 1,000 3.1500 3,150
2023-08-04 CTSO BATOR MICHAEL G. 1,000 3.2300 1,000 3.2300 3,230
2022-05-18 CTSO BATOR MICHAEL G. 2,000 2.1800 2,000 2.1800 4,360
2022-05-18 CTSO BATOR MICHAEL G. 2,000 2.1800 2,000 2.1800 4,360
2022-05-18 CTSO BATOR MICHAEL G. 2,000 2.2000 2,000 2.2000 4,400
2022-05-18 CTSO BATOR MICHAEL G. 2,000 2.2000 2,000 2.2000 4,400
2022-05-18 CTSO BATOR MICHAEL G. 2,000 2.2000 2,000 2.2000 4,400
2022-05-18 CTSO BATOR MICHAEL G. 1,000 2.2100 1,000 2.2100 2,210
2017-06-09 CTSO BATOR MICHAEL G. 1,500 4.1200 1,500 4.1200 6,180
2016-06-07 CTSO BATOR MICHAEL G. 3,000 4.8800 3,000 4.8800 14,640

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CTSO / Cytosorbents Corporation Insider Trades
Insider Sales CTSO / Cytosorbents Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CTSO / Cytosorbents Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CTSO / Cytosorbents Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Bator Michael G. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-03-04 2025-02-24 4 CTSO Cytosorbents Corp
Common Stock
O - Other 10,000 151,273 7.08 1.13 11,300 170,938
2025-01-22 2025-01-17 4 CTSO Cytosorbents Corp
Common Stock
X - Other 15,879 141,273 12.66 1.00 15,879 141,273
2023-12-15 2023-12-13 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 37,594 125,394 42.82 1.33 50,000 166,774
2023-08-08 2023-08-07 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 1,000 87,800 1.15 3.15 3,150 276,570
2023-08-08 2023-08-07 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 1,000 86,800 1.17 3.20 3,200 277,760
2023-08-08 2023-08-04 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 1,000 85,800 1.18 3.23 3,230 277,134
2022-05-19 2022-05-18 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 1,000 84,800 1.19 2.21 2,210 187,408
2022-05-19 2022-05-18 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 2,000 83,800 2.44 2.20 4,400 184,360
2022-05-19 2022-05-18 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 2,000 83,800 2.44 2.20 4,400 184,360
2022-05-19 2022-05-18 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 2,000 81,800 2.51 2.20 4,400 179,960
2022-05-19 2022-05-18 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 2,000 77,800 2.64 2.18 4,360 169,604
2022-05-19 2022-05-18 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 2,000 77,800 2.64 2.18 4,360 169,604
2021-04-14 2021-04-12 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 17,250 17,250
2020-03-03 2020-02-28 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 15,000 15,000
2019-07-24 2019-07-22 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 15,000 15,000
2018-04-27 2018-03-15 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 14,450 14,450
2018-04-27 2018-03-15 4 CTSO Cytosorbents Corp
Common Stock
A - Award 3,300 73,800 4.68
2017-06-12 2017-06-09 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 1,500 70,500 2.17 4.12 6,180 290,460
2017-02-28 2017-02-24 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 13,750 13,750
2017-02-28 2017-02-24 4 CTSO Cytosorbents Corp
Common Stock
A - Award 6,000 69,000 9.52
2016-06-09 2016-06-07 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 12,000 12,000
2016-06-09 2016-06-07 4 CTSO Cytosorbents Corp
Common Stock
A - Award 60,000 63,000 2,000.00
2016-06-09 2016-06-07 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 3,000 3,000 4.88 14,640 14,640
2016-06-06 2016-06-03 4 CTSO Cytosorbents Corp
Common Stock
A - Award 1,000 2,000 100.00 4.49 4,490 8,980
2016-06-06 2016-06-02 4 CTSO Cytosorbents Corp
Common Stock
A - Award 1,000 1,000 4.49 4,490 4,490
2015-07-15 2015-07-14 4 CTSO Cytosorbents Corp
Stock Option
A - Award 6,000 6,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)